Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001889701 | SCV002161942 | pathogenic | Rett syndrome, congenital variant | 2021-09-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe265Argfs*56) in the FOXG1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 225 amino acid(s) of the FOXG1 protein. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FOXG1 protein in which other variant(s) (p.Arg274Gln) have been determined to be pathogenic (PMID: 28554332). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with FOXG1-related conditions. This variant is not present in population databases (ExAC no frequency). |